Matrix metalloproteinase sensitive gold nanorod for simultaneous bioimaging and photothermal therapy of cancer.

PubWeight™: 0.96‹?› | Rank: Top 15%

🔗 View Article (PMID 21062090)

Published in Bioconjug Chem on November 09, 2010

Authors

Dong Kee Yi1, In-Cheol Sun, Ju Hee Ryu, Heebeom Koo, Chul Wan Park, In-Chan Youn, Kuiwon Choi, Ick Chan Kwon, Kwangmeyung Kim, Cheol-Hee Ahn

Author Affiliations

1: Division of Bionanotechnology, Gachon Bionano Institute, Kyungwon University, Geonggi-do 461-701, Korea.

Articles citing this

Gold nanorods based platforms for light-mediated theranostics. Theranostics (2013) 1.11

Preventing protein adsorption and macrophage uptake of gold nanoparticles via a hydrophobic shield. ACS Nano (2012) 1.07

In vivo particle tracking and photothermal ablation using plasmon-resonant gold nanostars. Nanomedicine (2012) 1.02

Nanotheranostics--a review of recent publications. Int J Nanomedicine (2012) 1.02

Multifunctional gold nanostar conjugates for tumor imaging and combined photothermal and chemo-therapy. Theranostics (2013) 0.97

Synergistic effects of cisplatin chemotherapy and gold nanorod-mediated hyperthermia on ovarian cancer cells and tumors. Nanomedicine (Lond) (2014) 0.96

Role of surface modification in zinc oxide nanoparticles and its toxicity assessment toward human dermal fibroblast cells. Int J Nanomedicine (2014) 0.79

Hyaluronic Acid Modified Hollow Prussian Blue Nanoparticles Loading 10-hydroxycamptothecin for Targeting Thermochemotherapy of Cancer. Theranostics (2016) 0.78

Modulation of the tumor microenvironment for cancer treatment: a biomaterials approach. J Funct Biomater (2015) 0.78

Manganese (II) Chelate Functionalized Copper Sulfide Nanoparticles for Efficient Magnetic Resonance/Photoacoustic Dual-Modal Imaging Guided Photothermal Therapy. Theranostics (2015) 0.78

Probing the behaviors of gold nanorods in metastatic breast cancer cells based on UV-vis-NIR absorption spectroscopy. PLoS One (2012) 0.78

In situ activation and monitoring of the evolution of the intracellular caspase family. Chem Sci (2015) 0.75

A54 peptide-mediated functionalized gold nanocages for targeted delivery of DOX as a combinational photothermal-chemotherapy for liver cancer. Int J Nanomedicine (2017) 0.75

Articles by these authors

Multifunctional nanoparticles for multimodal imaging and theragnosis. Chem Soc Rev (2011) 2.05

Cellular uptake mechanism and intracellular fate of hydrophobically modified glycol chitosan nanoparticles. J Control Release (2009) 1.81

Tumor targeting efficiency of bare nanoparticles does not mean the efficacy of loaded anticancer drugs: importance of radionuclide imaging for optimization of highly selective tumor targeting polymeric nanoparticles with or without drug. J Control Release (2010) 1.51

Super pH-sensitive multifunctional polymeric micelle for tumor pH(e) specific TAT exposure and multidrug resistance. J Control Release (2008) 1.50

Targeted delivery of low molecular drugs using chitosan and its derivatives. Adv Drug Deliv Rev (2009) 1.46

Tumor targetability and antitumor effect of docetaxel-loaded hydrophobically modified glycol chitosan nanoparticles. J Control Release (2008) 1.44

Self-assembled hyaluronic acid nanoparticles for active tumor targeting. Biomaterials (2009) 1.43

A near-infrared-fluorescence-quenched gold-nanoparticle imaging probe for in vivo drug screening and protease activity determination. Angew Chem Int Ed Engl (2008) 1.43

Functional enhancement of beta cells in transplanted pancreatic islets by secretion signal peptide-linked exendin-4 gene transduction. J Control Release (2012) 1.41

Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy. J Control Release (2008) 1.38

Tumor-homing multifunctional nanoparticles for cancer theragnosis: Simultaneous diagnosis, drug delivery, and therapeutic monitoring. J Control Release (2010) 1.37

Biodistribution and anti-tumor efficacy of doxorubicin loaded glycol-chitosan nanoaggregates by EPR effect. J Control Release (2003) 1.34

Cell-permeable and biocompatible polymeric nanoparticles for apoptosis imaging. J Am Chem Soc (2006) 1.33

Self-assembled nanoparticles based on glycol chitosan bearing hydrophobic moieties as carriers for doxorubicin: in vivo biodistribution and anti-tumor activity. Biomaterials (2006) 1.32

Activatable imaging probes with amplified fluorescent signals. Chem Commun (Camb) (2008) 1.32

Antitumor efficacy of cisplatin-loaded glycol chitosan nanoparticles in tumor-bearing mice. J Control Release (2007) 1.29

Polymeric nanoparticle-based activatable near-infrared nanosensor for protease determination in vivo. Nano Lett (2009) 1.29

Real-time video imaging of protease expression in vivo. Theranostics (2011) 1.27

Porous chitosan scaffold containing microspheres loaded with transforming growth factor-beta1: implications for cartilage tissue engineering. J Control Release (2003) 1.22

Visualization of the degradation of a disulfide polymer, linear poly(ethylenimine sulfide), for gene delivery. Bioconjug Chem (2007) 1.22

Effect of polymer molecular weight on the tumor targeting characteristics of self-assembled glycol chitosan nanoparticles. J Control Release (2007) 1.18

Smart nanocarrier based on PEGylated hyaluronic acid for cancer therapy. ACS Nano (2011) 1.18

Heparin-coated gold nanoparticles for liver-specific CT imaging. Chemistry (2009) 1.17

Engineered polymers for advanced drug delivery. Eur J Pharm Biopharm (2008) 1.17

Self-assembled nanoparticles containing hydrophobically modified glycol chitosan for gene delivery. J Control Release (2005) 1.16

Tumor-targeting peptide conjugated pH-responsive micelles as a potential drug carrier for cancer therapy. Bioconjug Chem (2010) 1.16

Protease imaging of human atheromata captures molecular information of atherosclerosis, complementing anatomic imaging. Arterioscler Thromb Vasc Biol (2010) 1.14

In vivo targeted delivery of nanoparticles for theranosis. Acc Chem Res (2011) 1.13

Self-assembled glycol chitosan nanoparticles for the sustained and prolonged delivery of antiangiogenic small peptide drugs in cancer therapy. Biomaterials (2008) 1.12

Self-assembled nanoparticles based on hyaluronic acid-ceramide (HA-CE) and Pluronic® for tumor-targeted delivery of docetaxel. Biomaterials (2011) 1.10

Theranostic nanoparticles based on PEGylated hyaluronic acid for the diagnosis, therapy and monitoring of colon cancer. Biomaterials (2012) 1.10

Gold nanoparticles surface-functionalized with paclitaxel drug and biotin receptor as theranostic agents for cancer therapy. Biomaterials (2011) 1.10

Bioorthogonal copper-free click chemistry in vivo for tumor-targeted delivery of nanoparticles. Angew Chem Int Ed Engl (2012) 1.09

Photosensitizer-conjugated human serum albumin nanoparticles for effective photodynamic therapy. Theranostics (2011) 1.09

Doxorubicin loaded pH-sensitive micelle: antitumoral efficacy against ovarian A2780/DOXR tumor. Pharm Res (2008) 1.07

The effect of surface functionalization of PLGA nanoparticles by heparin- or chitosan-conjugated Pluronic on tumor targeting. J Control Release (2010) 1.07

PEGylation of hyaluronic acid nanoparticles improves tumor targetability in vivo. Biomaterials (2010) 1.07

Conjugated polymer nanoparticles for biomedical in vivo imaging. Chem Commun (Camb) (2010) 1.07

The hydrogel template method for fabrication of homogeneous nano/microparticles. J Control Release (2009) 1.07

Dark quenched matrix metalloproteinase fluorogenic probe for imaging osteoarthritis development in vivo. Bioconjug Chem (2008) 1.06

Tumor specificity and therapeutic efficacy of photosensitizer-encapsulated glycol chitosan-based nanoparticles in tumor-bearing mice. Biomaterials (2009) 1.05